281 related articles for article (PubMed ID: 14744827)
21. Minimum-norm estimation for binormal receiver operating characteristic (ROC) curves.
Davidov O; Nov Y
Biom J; 2009 Dec; 51(6):1030-46. PubMed ID: 19894216
[TBL] [Abstract][Full Text] [Related]
22. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
Tanaka N; Fujimoto K; Yoshikawa M; Tanaka M; Hirao Y; Kondo H; Saito I
Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of confounding effects in ROC studies.
Le CT
Biometrics; 1997 Sep; 53(3):998-1007. PubMed ID: 9290227
[TBL] [Abstract][Full Text] [Related]
24. Advanced integrated technique in breast cancer thermography.
Ng EY; Kee EC
J Med Eng Technol; 2008; 32(2):103-14. PubMed ID: 17852648
[TBL] [Abstract][Full Text] [Related]
25. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716
[TBL] [Abstract][Full Text] [Related]
26. Nonparametric estimation of ROC curves in the absence of a gold standard.
Zhou XH; Castelluccio P; Zhou C
Biometrics; 2005 Jun; 61(2):600-9. PubMed ID: 16011710
[TBL] [Abstract][Full Text] [Related]
27. Determination of the relative probability for prostate cancer to avoid unnecessary biopsy.
Okamura K; Takaba H; Kamihira O; Kinukawa T; Ono Y; Ohshima S; Nagasaka T
Int J Urol; 2005 Apr; 12(4):346-52. PubMed ID: 15948720
[TBL] [Abstract][Full Text] [Related]
28. Semiparametric ROC surfaces for continuous diagnostic tests based on two test measurements.
Wan S; Zhang B
Stat Med; 2009 Aug; 28(18):2370-83. PubMed ID: 19499550
[TBL] [Abstract][Full Text] [Related]
29. ROC analysis for markers with mass at zero.
Schisterman EF; Reiser B; Faraggi D
Stat Med; 2006 Feb; 25(4):623-38. PubMed ID: 16345033
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen levels as a predictor of lethal prostate cancer.
Fall K; Garmo H; Andrén O; Bill-Axelson A; Adolfsson J; Adami HO; Johansson JE; Holmberg L;
J Natl Cancer Inst; 2007 Apr; 99(7):526-32. PubMed ID: 17405997
[TBL] [Abstract][Full Text] [Related]
31. Transformation-invariant and nonparametric monotone smooth estimation of ROC curves.
Du P; Tang L
Stat Med; 2009 Jan; 28(2):349-59. PubMed ID: 18985706
[TBL] [Abstract][Full Text] [Related]
32. An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks data.
Ng SK; McLachlan GJ
Stat Med; 2003 Apr; 22(7):1097-111. PubMed ID: 12652556
[TBL] [Abstract][Full Text] [Related]
33. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
Liu JP; Ma MC; Wu CY; Tai JY
Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
[TBL] [Abstract][Full Text] [Related]
34. [Does plasmatic dilution influence the validity of PSA-tests?].
Rohde D; Mihelcic V
Aktuelle Urol; 2007 Mar; 38(2):137-43. PubMed ID: 17390276
[TBL] [Abstract][Full Text] [Related]
35. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels.
Tanaka N; Fujimoto K; Chihara Y; Torimoto M; Hirao Y; Konishi N; Saito I
Prostate Cancer Prostatic Dis; 2007; 10(3):274-8. PubMed ID: 17339878
[TBL] [Abstract][Full Text] [Related]
36. Review of the new methodology of analyzing receiver operating characteristic curves.
Ikeda M; Ishigaki T; Yamauchi K
Stud Health Technol Inform; 1998; 52 Pt 2():837-40. PubMed ID: 10384578
[TBL] [Abstract][Full Text] [Related]
37. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
Filella X; Truan D; Alcover J; Quintó L; Molina R; Luque P; Coca F; Ballesta AM
Urology; 2004 Jun; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958
[TBL] [Abstract][Full Text] [Related]
38. [ROC (receiver operating characteristics) curve: principles and application in biology].
Delacour H; Servonnet A; Perrot A; Vigezzi JF; Ramirez JM
Ann Biol Clin (Paris); 2005; 63(2):145-54. PubMed ID: 15771972
[TBL] [Abstract][Full Text] [Related]
39. Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: results of a prospective multicenter study.
Sözen S; Eskicorapci S; Küpeli B; Irkilata L; Altinel M; Ozer G; Uygur C; Alkibay T; Ozen H
Eur Urol; 2005 Mar; 47(3):302-7. PubMed ID: 15716190
[TBL] [Abstract][Full Text] [Related]
40. The optimal ratio of cases to controls for estimating the classification accuracy of a biomarker.
Janes H; Pepe M
Biostatistics; 2006 Jul; 7(3):456-68. PubMed ID: 16428259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
